Soleus Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-45,500
| Closed | -$872K | – | 94 |
|
|
2024
Q4 | $872K | Sell |
45,500
-49,500
| -52% | -$949K | 0.05% | 74 |
|
|
2024
Q3 | $2.16M | Sell |
95,000
-245,000
| -72% | -$5.57M | 0.17% | 76 |
|
|
2024
Q2 | $4.42M | Hold |
340,000
| – | – | 0.39% | 65 |
|
|
2024
Q1 | $5.95M | Buy |
340,000
+202,000
| +146% | +$3.54M | 0.44% | 60 |
|
|
2023
Q4 | $3.01M | Buy |
+138,000
| New | +$3.01M | 0.33% | 49 |
|
|
2023
Q3 | – | Sell |
-34,000
| Closed | -$809K | – | 115 |
|
|
2023
Q2 | $809K | Buy |
+34,000
| New | +$809K | 0.09% | 87 |
|
|
2022
Q4 | – | Sell |
-19,518
| Closed | -$400K | – | 91 |
|
|
2022
Q3 | $400K | Sell |
19,518
-821,500
| -98% | -$16.8M | 0.05% | 76 |
|
|
2022
Q2 | $9.73M | Buy |
841,018
+751,018
| +834% | +$8.69M | 1.52% | 21 |
|
|
2022
Q1 | $1.66M | Hold |
90,000
| – | – | 0.21% | 58 |
|
|
2021
Q4 | $1.78M | Buy |
+90,000
| New | +$1.78M | 0.18% | 52 |
|
|
2021
Q2 | – | Sell |
-67,685
| Closed | -$1.13M | – | 77 |
|
|
2021
Q1 | $1.13M | Sell |
67,685
-13,500
| -17% | -$226K | 0.2% | 63 |
|
|
2020
Q4 | $1.34M | Buy |
+81,185
| New | +$1.34M | 0.18% | 47 |
|